The use of totally implantable central venous access ports for the treatment of multidrug-resistant tuberculosis (MDR-TB) at the programmatic level. Prospective cohort study
A. Skrahin (Minsk, Belarus), D. Pechinski (Minsk, Belarus), M. Makouski (Minsk, Belarus), H. Hurevich (Minsk, Belarus), A. Sinha (Minsk, Belarus), S. Aliushin (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Skrahina (Minsk, Belarus)
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Session: Tuberculosis and non-TB mycobacterial infection II
Session type: Thematic Poster
Number: 4637
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Skrahin (Minsk, Belarus), D. Pechinski (Minsk, Belarus), M. Makouski (Minsk, Belarus), H. Hurevich (Minsk, Belarus), A. Sinha (Minsk, Belarus), S. Aliushin (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Skrahina (Minsk, Belarus). The use of totally implantable central venous access ports for the treatment of multidrug-resistant tuberculosis (MDR-TB) at the programmatic level. Prospective cohort study. 4637
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: